TPI Enterprises Ltd v Tasmanian Alkaloids Pty Ltd

Link copied
Case Copied 63 min read

IP AUSTRALIA

AUSTRALIAN PATENT OFFICE

TPI Enterprises Ltd v Tasmanian Alkaloids Pty Ltd [2018] APO 8

Patent Application:                2009253741

Title:Papaver somniferum with high concentration of codeine

Patent Applicant:                   Tasmanian Alkaloids Pty Ltd

Opponent:  TPI Enterprises Ltd

Delegate:  Dr S. J. Smith

Decision Date:  31 January 2018

Hearing Date:  15 June 2017 in Canberra

Catchwords:  PATENTS – opposition to the grant of a patent – grounds of manner of manufacture and inventive step – not established that the claims encompass naturally-occurring subject matter – manner of manufacture ground not successful – inventive step – expectation of success not established – inventive step ground not successful – costs awarded against opponent

Representation:  Counsel for the applicant: Ms Katrina Howard SC

Patent attorney for the applicant: Dr Charles Tansey of Shelston IP

Counsel for the opponent: Mr Gerard Dalton QC

Solicitor for the opponent: Mr Zaven Mardirossian and Ms Claire Southwell of Arnold Bloch Leibler

IP AUSTRALIA

AUSTRALIAN PATENT OFFICE

Patent Application:                2009253741

Title:Papaver somniferum with high concentration of codeine

Patent Applicant:                   Tasmanian Alkaloids Pty Ltd

Date of Decision:                   31 January 2018

DECISION

The opposition is unsuccessful.  Subject to appeal of this decision or Sun Pharmaceutical Industries (Australia) Pty Ltd v Tasmanian Alkaloids Pty Ltd [2018] APO 7 I direct that the application proceed to grant.

I award costs according to Schedule 8 against TPI Enterprises Ltd.

REASONS FOR DECISION

Background

  1. Patent application 2009253741 was filed by Tasmanian Alkaloids Pty Limited (TasAlk) on 28 May 2009 under the provisions of the Patent Cooperation Treaty.  The application claims priority from US 61/056,880, US 61/160,532 and US 61/160,749, which were filed on 29 May 2008, 16 March 2009 and 17 March 2009, respectively.

  2. Acceptance of the application was advertised on 11 June 2015.  TPI Enterprises Ltd (TPI) filed a notice of opposition under section 59 on 7 September 2015 and a hearing was held in Canberra on 15 June 2017.  This decision relates to the opposition by TPI.  Sun Pharmaceutical Industries (Australia) Pty Ltd also opposed grant of the application and the decision in relation to that opposition is reported as Sun Pharmaceutical Industries (Australia) Pty Ltd v Tasmanian Alkaloids Pty Ltd [2018] APO 7 (the Sun opposition).

  3. TasAlk proposed post-acceptance amendments to the specification on 22 April 2016 which were allowed unopposed on 17 August 2016.  This decision is in relation to the specification as amended.

    The Opposition

  1. The statement of grounds and particulars was filed on 11 December 2015 and set out the following grounds of opposition: manner of manufacture, inventive step and fair basis.  Manner of manufacture and inventive step were pressed at the hearing, with manner of manufacture limited to the particular basis that the claims include naturally-occurring subject matter.  An amended statement of grounds and particulars reflecting those grounds was filed on 20 June 2017 and the amendment allowed on 21 July 2017.

    Evidence

  2. The evidence filed during the evidentiary periods is summarised in the table below:

Evidence Declarant Exhibits Date of declaration Reference

In…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read TPI Enterprises Ltd v Tasmanian Alkaloids Pty Ltd and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2018] APO 8
Decision Date

CaseChat Overview and Summary

The applicant, Tasmanian Alkaloids Pty Ltd, filed a patent application for a method of producing a poppy plant with a high concentration of codeine. The application was opposed by TPI Enterprises Ltd, which argued that the invention was not novel, did not involve an inventive step and was not a manner of manufacture. The applicant also faced opposition from Sun Pharmaceutical Industries (Australia) Pty Ltd, but that opposition was unsuccessful and is reported in Sun Pharmaceutical Industries (Australia) Pty Ltd v Tasmanian Alkaloids Pty Ltd [2018] APO 7. The decision of Dr Smith, the delegate of the Commissioner of Patents, was that the opposition was unsuccessful. TPI did not establish that the claims were not for a manner of manufacture, or that they lacked an inventive step. Costs were awarded to the applicant. The invention relates to a Papaver somniferum plant which upon harvesting yields a poppy straw with a high proportion of codeine. The specification describes the use of mutagenesis to produce poppies with an altered alkaloid profile. The claims encompass plants which yield a high proportion of codeine, and plants which when crossed with certain poppies yield progeny with a high proportion of codeine. Dr Smith was not persuaded by TPI's submission that the claims encompassed naturally-occurring poppies. He found that the evidence did not establish that it was clear or practically certain that the claims encompassed naturally-occurring poppies. Dr Smith found that TPI had not established that the invention lacked an inventive step in light of common general knowledge alone or in light of the prior art. The evidence established that it was known that a high codeine poppy was a desirable goal, and that mutagenesis and screening was a known technique for producing poppies with altered alkaloid profiles. However, Dr Smith was not satisfied that the evidence established that it was clear or practically certain that the skilled worker would have had a reasonable expectation of success in obtaining a high codeine poppy. The opposition was therefore unsuccessful.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.